Circulation miR-193 cluster serves as a promising biomarker for diagnosis of breast cancer / 临床检验杂志
Chinese Journal of Clinical Laboratory Science
;
(12): 574-578, 2019.
Artigo
em Chinês
| WPRIM
| ID: wpr-821757
ABSTRACT
Objective@#To evaluate circulating miR-193 cluster as a biomarker for diagnosis of breast cancer (BC). @*Methods@#A total of 130 BC patients and 45 healthy controls (HCs) were enrolled. The level of miR-193 cluster was analyzed by using GEO database. RT-qPCR was used to evaluate the level of miR-193 cluster in serum of participants. Receivers operating characteristic (ROC) curve analysis was manipulated to investigate their diagnostic value for BC. @*Results@#In the screening stage, the results of GEO database indicated the expression of miR-193a-5p and miR-193b were decreased in the serum of BC patients with prior diagnostic value, and the significant decreased expressions of miR-193 cluster members, miR-193a-3p, -5p and miR-193b-3p, were observed in serum of BC patients compared with those in healthy controls by the determination of RT-qPCR(all P <0.01). In the validation stage, the AUCROC of miR-193a-5p and miR-193b-5p were 0.888 (95% CI0.808-0.969) and 0.954 (95% CI0.902-1.000), respectively. In addition, the combined AUCROC of these two miRNAs was 0.982 (95% CI0.966-0.999). @*Conclusion@#miR-193a-5p and miR-193b-5p in serum could be served as diagnostic biomarker for screening of breast cancer, and the combined detections of the two miRNAs may exhibit more diagnostic efficiency and good clinical application potential.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Tipo de estudo:
Estudo diagnóstico
/
Estudo prognóstico
Idioma:
Chinês
Revista:
Chinese Journal of Clinical Laboratory Science
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS